Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Piel is a health-technology company that provides a personalized, telehealth-driven approach to prescription skincare. The company connects patients with licensed medical providers who evaluate skin concerns and prescribe customized topical formulations containing active ingredients such as tretinoin, clindamycin, and azelaic acid. Piel's business model focuses on a subscription-based service that delivers these medical-grade treatments directly to consumers' homes. By integrating clinical expertise with a digital-first platform, Piel aims to make dermatological care more accessible and tailored to individual skin types and goals.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Piel.